GENEZINI, FREDERICO A.ZAHN, GUILHERME S.SILVA, PAULO S.C. daNORY, RENATA M.MOREIRA, EDSON G.SANTIAGO, PAULO S.2020-01-072020-01-07GENEZINI, FREDERICO A.; ZAHN, GUILHERME S.; SILVA, PAULO S.C. da; NORY, RENATA M.; MOREIRA, EDSON G.; SANTIAGO, PAULO S. On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route. In: INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE, October 21-25, 2019, Santos, SP. <b>Proceedings...</b> Rio de Janeiro: Associação Brasileira de Energia Nuclear, 2019. p. 1759-1765. Disponível em: http://repositorio.ipen.br/handle/123456789/30580.http://repositorio.ipen.br/handle/123456789/30580Over the last years the 177Lu radioisotope has attracted great interest for the use in therapeutic and diagnostic procedures simultaneously, being what is now called a theranostic radioisotope. There are mainly two ways of producing this radioisotope, by direct neutron capture in a 176Lu target (the \direct route") or by irradiating a 176Yb sample, producing 177Yb that will then decay to 177Lu (also referred as the \indirect route"). In this work the feasibility of producing 177Lu in the IEA-R1 nuclear reactor via the direct route was assessed, and the speci c activity that could be obtained was estimated both experimentally and theoretically, allowing for a discussion on the feasibility of commercially producing 177Lu by 176Lu neutron capture in the IEA-R1 reactor.1759-1765openAccesscapturefeasibility studiesiear-1 reactorisotope productionlutetium 176 targetlutetium 177neutron reactionsnuclear medicinetherapyTexto completo de evento0000-0002-6318-6805https://orcid.org/0000-0002-9351-9201https://orcid.org/0000-0003-3237-8588https://orcid.org/0000-0002-6318-6805